Your browser doesn't support javascript.
loading
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.
Padron, E; Garcia-Manero, G; Patnaik, M M; Itzykson, R; Lasho, T; Nazha, A; Rampal, R K; Sanchez, M E; Jabbour, E; Al Ali, N H; Thompson, Z; Colla, S; Fenaux, P; Kantarjian, H M; Killick, S; Sekeres, M A; List, A F; Onida, F; Komrokji, R S; Tefferi, A; Solary, E.
Afiliación
  • Padron E; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Patnaik MM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Itzykson R; Service d'Hematologie, Hopital Avicenne, Bobigny, France.
  • Lasho T; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Nazha A; Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Rampal RK; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sanchez ME; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Al Ali NH; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Thompson Z; Department of Biostatistics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Colla S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fenaux P; Service d'Hématologie Séniors, Hôpital St Louis, Université Paris 7, Paris, France.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Killick S; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Sekeres MA; Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • List AF; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Onida F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
  • Komrokji RS; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Tefferi A; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Solary E; Gustave Roussy, INSERM U1170, Villejuif, France.
Blood Cancer J ; 5: e333, 2015 Jul 31.
Article en En | MEDLINE | ID: mdl-26230957
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielomonocítica Crónica Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielomonocítica Crónica Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos